glp-1 intracranial hypertension medications and pseudotumor cerebri / idiopathic #pseudotumorcerebri #iih Novel use of GLP-1 receptor

The 8.5mg/mL formulation is designed for lower doses (2.5mg to 5mg weekly) and results in larger injection volumes that are easier to measure accurately

Science-backed weight loss Clinical studies with Ozempic showed: ~40% of users lost 10% or more body weight ~20% of users lost 20% or more body weight Common side effects Side effects include but are not limited to nausea, heartburn, hypoglycemia, constipation, and diarrhea

Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts

Exenatide Once Weekly for Alcohol Use Disorder Investigated in a Randomized, Placebo-Controlled Clinical Trial

These trials showed that semaglutide resulted in an average body weight reduction ranging from 8.4% up to 17% from baseline weight among participants

What is Sermorelin Therapy